Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia

Vascular Health and Risk Management

Volumn 10, Issue , 2014, Pages 367-374

  Siracuse, Jeffrey J ^a   Huang, Zhen S ^a   Gill, Heather L ^a   Parrack, Inkyong ^a   Schneider, Darren B ^a   Connolly, Peter H ^a   Meltzer, Andrew J ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Adverse events; Bypass; Critical limb ischemia

Indexed keywords

CREATININE; HEPARIN; POLITEF; STEROID;

AFRICAN AMERICAN; AGE DISTRIBUTION; AGING; ALLOGRAFT; ARTERY ANASTOMOSIS; ARTERY CALCIFICATION; ARTERY OCCLUSION; ATHEROSCLEROSIS; BACTERIUM ISOLATION; BIOLOGICAL MODEL; BLOOD VESSEL PROSTHESIS; BYPASS SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CEPHALIC VEIN; CLAUDICATION; CLINICAL DECISION MAKING; COMMON FEMORAL ARTERY OCCLUSION; COMMON FEMORAL ENDARTERECTOMY; COMORBIDITY; CORONARY ARTERY BYPASS SURGERY; CREATININE BLOOD LEVEL; CRITICAL LIMB ISCHEMIA; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIABETIC FOOT; DIALYSIS; DISEASE SEVERITY; DRUG ELUTING STENT; DRUG USE; DYSPNEA; END STAGE RENAL DISEASE; ENDARTERECTOMY; ENDOVASCULAR SURGERY; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GRAFT FAILURE; GRAFT INFECTION; GRAFT PATENCY; GRAFT SURVIVAL; HEALTH CARE QUALITY; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITAL READMISSION; HOSPITALIZATION COST; HUMAN; INFECTION RISK; INFRAMALLEOLAR BYPASS; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LEG AMPUTATION; LEG CRAMP; LEG PAIN; LEG REVASCULARIZATION; LENGTH OF STAY; LIMB SALVAGE; LOWER EXTREMITY BYPASS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMALLY INVASIVE SURGERY; MORBIDITY; OBESITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE EVALUATION; PROFUNDAPLASTY; PROJECT OF EX VIVO VEIN GRAFT ENGINEERING VIA TRANSFECTION III SCORE; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RACE DIFFERENCE; RATING SCALE; REVIEW; REVISED CARDIAC RISK INDEX; RISK ASSESSMENT; SAPHENOUS VEIN; SAPHENOUS VEIN CONDUIT; SAPHENOUS VEIN GRAFT; SEPSIS; SEX DIFFERENCE; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; THROMBOEMBOLISM; TIBIAL VESSEL BYPASS; VACUUM ASSISTED CLOSURE; WOUND INFECTION; ADVERSE EFFECTS; BLOOD VESSEL GRAFT; CRITICAL ILLNESS; ISCHEMIA; LEG; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; TREATMENT OUTCOME; VASCULARIZATION;

CRITICAL ILLNESS; HUMANS; ISCHEMIA; LOWER EXTREMITY; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VASCULAR GRAFTING;

EID: 84903761382     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S54350     Document Type: Review

References (45)

1. Varu VN, Hogg ME, Kibbe MR. Critical limb ischemia. J Vasc Surg. 2010;51(1):230-241.
2. DeRubertis BG, Faries PL, McKinsey JF, et al. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg. 2007;246(3):415-422. discussion 422-424.
3. Gallagher KA, Meltzer AJ, Ravin RA, et al. Endovascular management as frst therapy for chronic total occlusion of the lower extremity arteries: comparison of balloon angioplasty, stenting, and directional atherectomy. J Endovasc Ther. 2011;18(5):624-637.
4. Siracuse JJ, Giles KA, Pomposelli FB, et al. Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease. J Vasc Surg. 2012;55(4):1001-1007.
5. Bradbury AW, Adam DJ, Bell J, et al; BASIL Trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making. J Vasc Surg. 2010;51(Suppl 5):52S-68S.
6. Meltzer AJ, Graham A, Connolly PH, et al. The Comprehensive Risk Assessment for Bypass (CRAB) facilitates effcient perioperative risk assessment for patients with critical limb ischemia. J Vasc Surg. 2013;57(5):1186-1195.
7. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg. 2005;42(3):456-464. discussion 464-465.
8. Menke H, Klein A, John KD, Junginger T. Predictive value of ASA classifcation for the assessment of the perioperative risk. Int Surg. 1993;78(3):266-270.
9. Sutton R, Bann S, Brooks M, Sarin S. The Surgical Risk Scale as an improved tool for risk-adjusted analysis in comparative surgical audit. Br J Surg. 2002;89(6):763-768.
10. Cohen ME, Bilimoria K Y, Ko C Y, Hall BL. Development of an American College of Surgeons National Surgery Quality Improvement Program: morbidity and mortality risk calculator for colorectal surgery. J Am Coll Surg. 2009;208(6):1009-1016.
11. Kwok AC, Lipsitz SR, Bader AM, Gawande AA. Are targeted preopera-tive risk prediction tools more powerful? A test of models for emergency colon surgery in the very elderly. J Am Coll Surg. 2011;213(2): 220-225.
12. Ramanan B, Gupta PK, Gupta H, Fang X, Forse RA. Development and validation of a bariatric surgery mortality risk calculator. J Am Coll Surg. 2012;214(6):892-900.
13. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297(16):845-850.
14. Monahan TS, Shrikhande G V, Pomposelli FB, et al. Preoperative cardiac evaluation does not improve or predict perioperative or late survival in asymptomatic diabetic patients undergoing elective infrainguinal arterial reconstruction. J Vasc Surg. 2005;41(1):38-45. discussion 45.
15. Bertges DJ, Goodney P P, Zhao Y, et al; Vascular Study Group of New England. The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg. Sep 2010;52(3):674-683+683.e1-683.e3.
16. Crawford RS, Cambria R P, Abularrage CJ, et al. Preoperative functional status predicts perioperative outcomes after infrainguinal bypass surgery. J Vasc Surg. 2010;51(2):351-358. discussion 358-359.
17. Siracuse JJ, Gill HL, Jones DW, et al. Risk factors for protracted postoperative length of stay after lower extremity bypass for critical limb ischemia. Ann Vasc Surg. Epub February 8, 2014.
18. Pomposelli FB, Arora S, Gibbons G W, et al. Lower extremity arterial reconstruction in the very elderly: successful outcome preserves not only the limb but also residential status and ambulatory function. J Vasc Surg. 1998;28(2):215-225.
19. Vogel TR, Petroski GF, Kruse RL. Functional status of elderly adults before and after interventions for critical limb ischemia. J Vasc Surg. 2014;59(2):350-358.
20. Saltzberg SS, Pomposelli FB, Belfield AK, et al. Outcome of lower- extremity revascularization in patients younger than 40 years in a predominantly diabetic population. J Vasc Surg. 2003;38(5): 1056-1059.
21. Kwolek CJ, Pomposelli FB, Tannenbaum GA, et al. Peripheral vascular bypass in juvenile-onset diabetes mellitus: are aggressive revasculariza-tion attempts justifed? J Vasc Surg. 1992;15(2):394-400. discussion 400-401.
22. Lo RC, Bensley RP, Dahlberg SE, et al. Presentation, treatment, and outcome differences between men and women undergoing revascular-ization or amputation for lower extremity peripheral arterial disease. J Vasc Surg. 2014;59(2):409-418.
23. Siracuse JJ, Gill HL, Epelboym I, et al. Effect of race and insurance status on outcomes after vascular access placement for hemodialysis. Ann Vasc Surg. 2014;28(4):964-969.
24. Chew DK, Nguyen LL, Owens CD, et al. Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage. J Vasc Surg. 2005;42(4):695-701.
25. Gibbons G W, Burgess AM, Guadagnoli E, et al. Return to well-being and function after infrainguinal revascularization. J Vasc Surg. 1995;21(1):35-44. discussion 44-45.
26. McArthur CS, Sheahan MG, Pomposelli FB, et al. Infrainguinal revascularization after renal transplantation. J Vasc Surg. 2003;37(6): 1181-1185.
27. Hölzenbein TJ, Pomposelli FB, Miller A, et al. Results of a policy with arm veins used as the frst alternative to an unavailable ipsilateral greater saphenous vein for infrainguinal bypass. J Vasc Surg. 1996;23(1):130-140.
28. Hamdan AD, Rayan SS, Hook SC, et al. Bypasses to tibial vessels using polytetrafluoroethylene as the solo conduit in a predominantly diabetic population. Vasc Endovascular Surg. 2002;36(1): 59-63.
29. Dake MD, Ansel GM, Jaff MR, et al; Zilver PTX Investigators. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2 -year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol. 2013;61(24): 2417-2427.
30. Lammer J, Zeller T, Hausegger KA, et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superfcial femoral artery occlusive disease). J Am Coll Cardiol. 2013;62(15):1320-1327.
31. Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM; VIBRANT Investigators. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superfcial femoral artery occlusive disease. J Vasc Surg. 2013;58(2): 386-395.
32. Werk M, Albrecht T, Meyer DR, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5(6): 831-840.
33. Misare BD, Pomposelli FB, Gibbons GW, Campbell DR, Freeman DV, LoGerfo FW. Infrapopliteal bypasses to severely calcified, unclampable outfow arteries: two-year results. J Vasc Surg. 1996;24(1):6-15. discussion 15-16.
34. Tannenbaum GA, Pomposelli FB, Marcaccio EJ, et al. Safety of vein bypass grafting to the dorsal pedal artery in diabetic patients with foot infections. J Vasc Surg. 1992;15(6):982-988. discussion 989-990.
35. Hughes K, Domenig CM, Hamdan AD, et al. Bypass to plantar and tarsal arteries: an acceptable approach to limb salvage. J Vasc Surg. 2004;40(6):1149-1157.
36. Giles KA, Hamdan AD, Pomposelli FB, Wyers MC, Siracuse JJ, Schermerhorn ML. Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg. 2010;24(1):48-56.
37. Patel VI, Hamdan AD, Schermerhorn ML, et al. Lower extremity arterial revascularization in obese patients. J Vasc Surg. 2007;46(4):738-742.
38. Siracuse JJ, Nandivada P, Giles KA, et al. Prosthetic graft infections involving the femoral artery. J Vasc Surg. 2013;57(3):700-705.
39. Jansen RM, de Vries SO, Cullen KA, Donaldson MC, Hunink MG. Cost-identification analysis of revascularization procedures on patients with peripheral arterial occlusive disease. J Vasc Surg. 1998;28(4):617-623.
40. Goodney P P, Stukel TA, Lucas FL, Finlayson E V, Birkmeyer JD. Hospital volume, length of stay, and readmission rates in high-risk surgery. Ann Surg. 2003;238(2):161-167.
41. Collins TC, Daley J, Henderson WH, Khuri SF. Risk factors for prolonged length of stay after major elective surgery. Ann Surg. 1999;230(2):251-259.
42. McPhee JT, Nguyen LL, Ho KJ, Ozaki CK, Conte MS, Belkin M. Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia. J Vasc Surg. 2013;57(6):1481-1488.
43. Zhang JQ, Curran T, McCallum JC, et al. Risk factors for readmission after lower extremity bypass in the American College of Surgeons National Surgery Quality Improvement Program. J Vasc Surg. 2014;59(5):1331-1339.
44. Malgor RD, Ricotta JJ, Bower TC, et al. Common femoral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revascularization. Ann Vasc Surg. 2012;26(7): 946-956.
45. Siracuse JJ, Gill HL, Schneider DB, et al. Assessing the perioperative safety of common femoral endarterectomy in the endovascular era. Vasc Endovascular Surg. 2014;48(1):27-33.